Francesca Conradie
Lead Investigator

Dr Francesca Conradie, MBBCh, is a Clinical Research Specialist, her current research focus is in MDR-TB. Dr Conradie is the Principal investigator for the TB Alliance trial NIX that led to the registration of the new TB drug, Bedaquiline, and the implementation of its rollout. She is also holder of USAID Grant BEAT Tuberculosis, investigating a short, all oral regimen for RR-TB.